Skip to main content
2024 CRT Conference Main banner
Back

Philip Adamson, MD, MSc, FACC, FESC, FRCP (Ed)

Chief Medical Officer and Divisional Vice President
Abbott
Austin, Texas, United States

Philip B. Adamson, MD, MSc, FACC, FRCP (Ed) Chief Medical Officer and Divisional Vice President, Global Medical Affairs – Abbott Heart Failure Division
Dr. Adamson is responsible for global development of Abbott’s heart failure formulary including the CardioMEMS HF™ System, CentriMag temporary mechanical circulatory support and HeartMate 3 Left Ventricular Assist System. Dr. Adamson’s clinical interests are developing more efficient and effective heart failure disease management systems using remote monitoring of physiologic signals from implanted devices with the goal of advancing a comprehensive understanding of heart failure disease state and management. Dr. Adamson held leadership roles in several clinical trials including COMPASS-HF, CHAMPION, BLOCK-HF, GUIDE-HF and REDUCEhf.

Disclosure(s): Abbott Labs: Employee (Ongoing)

Presentation(s):

Email Philip